GADOBENATE DIMEGLUMINE

Search structure
Trade Names:
Synonyms:
Status: Approved (2004)
Entry Type: Small molecule
Molecule Category: UNKNOWN
UNII: 3Q6PPC19PO

Physicochemical Descriptors

Property Name Value
Molecular Formula C29H45GdN4O16
Molecular Weight 862.94
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
None Diagnostic agent DailyMed

Indications

Mesh Heading Maximum Phase Reference
Central Nervous System Diseases; Nervous System Diseases Phase 3 ClinicalTrials
Breast Neoplasms; Carcinoma, Ductal; Carcinoma in Situ; Carcinoma, Intraductal, Noninfiltrating Phase 2 ClinicalTrials
Peripheral Arterial Disease Phase 3 ClinicalTrials
Atrial Fibrillation; Coronary Artery Disease; Coronary Disease; Myocardial Ischemia Phase 2 ClinicalTrials

Adverse Reactions

SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
13.04
Nervous system disorders
12.76
Skin and subcutaneous tissue disorders
11.92
Respiratory, thoracic and mediastinal disorders
9.79
Immune system disorders
9.54
Vascular disorders
7.81
Gastrointestinal disorders
7.37
Cardiac disorders
6.82
Psychiatric disorders
5.23
Injury, poisoning and procedural complications
4.5
Musculoskeletal and connective tissue disorders
4.37
Investigations
2.38
Eye disorders
2.05

Cross References

Resources Reference
ChEMBL CHEMBL1200571
FDA SRS 3Q6PPC19PO
PubChem 197281
CONTENTS